While a mechanistic link between altered alanine metabolism and IDH status is unknown, Firdous et al determined alanine is a key metabolite for discriminating between glioma and non‐glioma tissue using untargeted NMR‐based metabolomics and machine learning.21 The gene discussed is IDH2; the disease is central nervous system cancer.